UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 18,555	$ 8,505	$ 12,128
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	765	660	610
Amortization	2,191	2,113	2,223
Gain on Investments	(32)	0	0
Provision for (recovery of) losses on accounts receivable	20	4	0
Loss/(Gain) on disposal of assets	(410)	17	5
Deferred income taxes	(326)	(658)	(484)
Stock-based compensation expense	64	129	92
Tax benefit attributable to exercise of stock options	49	0	0
Accounts receivable	(496)	(242)	295
Other receivables	0	2	897
Inventories	(244)	(467)	(360)
Prepaid expenses and other current assets	(68)	24	23
Accounts payable	52	9	286
Accrued expenses	(558)	1,027	(1,187)
Long-term repatriation tax payable	(2,728)	5,785	0
Net cash provided by operating activities	16,834	16,908	14,528
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(402)	(1,597)	(3,293)
Intangible assets	0	0	(9)
Proceeds from the sale of investments	74	0	0
Proceeds from the sale of property and equipment	862	0	0
Net cash provided by (used in) investing activities	534	(1,597)	(3,302)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	454	302	376
Common stock purchased and retired	(1,205)	0	(2,850)
Tax benefit attributable to exercise of stock options	0	0	50
Dividends paid	(4,026)	(2,955)	(3,916)
Net cash (used in) financing activities	(4,777)	(2,653)	(6,340)
Effect of exchange rate changes on cash	(1,354)	921	(1,868)
Net increase in cash and cash equivalents	11,237	13,579	3,018
Cash at beginning of year	39,875	26,296	23,278
Cash at end of year	51,112	39,875	26,296
Cash paid during the period for income taxes	4,851	5,151	4,846
Cash paid during the period for interest	$ 0	$ 0	$ 0